News

ASLAN Pharmaceuticals Announces Acceptance of Late Breaker Abstract on Eblasakimab Phase 2b Results as Oral Presentation and Three Additional Abstracts at 32nd European Academy of Dermatology and Venereology Congress

SAN MATEO, Calif. and SINGAPORE, Sept. 22, 2023 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company…

1 year ago

ZyVersa Therapeutics Announces Research Published in The Journal of Clinical Investigation Reinforcing IC 100’s Rationale for Inhibiting ASC Specks to Attenuate Spread of Inflammation into Surrounding Tissues

Patients with chronic kidney disease (“CKD”) exhibit chronic systemic inflammation characterized by increased circulating levels of IL-1β, IL-6, and CRP.This…

1 year ago

Faron Pharmaceuticals Ltd Results of the Extraordinary General Meeting

TURKU, Finland and BOSTON, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical-stage…

1 year ago

InvestmentPitch Media Video Discusses FSD Pharma’s Continued Development of its Exciting New Rapid Detox Drink UNBUZZD™, with Video Comments from Kevin Harrington

VANCOUVER, British Columbia, Sept. 22, 2023 (GLOBE NEWSWIRE) -- FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A), a biotechnology company building a…

1 year ago

Wandercraft bringt Atalante X, das erste selbststabilisierende Geh-Exoskelett der Welt, in Deutschland auf den Markt

Wandercraft bringt Atalante X, das erste selbststabilisierende Geh-Exoskelett der Welt, in Deutschland auf den Markt Zwei Atalante X-Exoskelette sind an…

1 year ago

Press Release: Availability of the Q3 2023 Memorandum for modelling purposes

Availability of the Q3 2023 Memorandum for modelling purposes Paris, France – September 22, 2023. Sanofi announced today that its…

1 year ago

MCI Onehealth Announces Voting Results of 2023 Annual General and Special Meeting of its Shareholders

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATESTORONTO, ON, Sept. 21, 2023 (GLOBE NEWSWIRE)…

1 year ago

Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer

ACTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world’s largest provider of hair testing for drugs of…

1 year ago

Ark-La-Tex Health Center Introduces New Advanced Regenerative Medicine Therapy with Unparalleled Results

TEXARKANA, Ark., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Ark-la-Tex Health Center is now offering a revolutionary new method in healing,…

1 year ago

AVITA Medical to Present at the Cantor Global Healthcare Conference

VALENCIA, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading…

1 year ago